Your search matched 89 results
Holistic healthcare brand Otsuka Pharmaceutical has announced a promising partnership with Science 37, the trailblazing startup out of MIT that’s transforming clinical trials for everyone.
The growing appeal of orphan drugs to manufacturers isn’t a groundbreaking story, but a new report identifies some head-spinning facts behind the focal shift from blockbuster to rare-disease drugs.
Pfizer and Novartis have been independently developing therapies for nonalcoholic steatohepatitis (NASH), and they’re now set to join forces to yield a combination therapy for the fatty liver disease linked closely with metabolic disorders.
Pharmaceutical giant Roche’s new app for people with multiple sclerosis (MS) revolutionizes how doctors care for patients with the disease.
Deploying ambassadors to speak at the marketing conference DigiPharma Connect, Snapchat is vying to position itself as the best social media outlet for pharma marketing.
Last week, many Amazon Prime members received more than their usual flow of order confirmations and shipping notifications, with the retail leviathan inviting some users to “Meet PillPack, a new member of the Amazon family.”
At the BrightInsight Ecosystem Event, which explores use cases and best practices in digital health, Harvard Business School Professor Gary Loveman shared some lessons for health care professionals gleaned from his unconventional career path.
Though pioneering a brand-new health-monitoring technology, scientists at the Technical University of Munich are doing it through an ancient art: tattoos.
Marked demographic shifts among American doctors are forecasting a new future for the profession.
Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.
Ten years after acquiring its competitor Duane Reade, Walgreens has set its sights on a whole different type of growth, announcing its plan to establish doctor’s offices in hundreds of its familiar brick-and-mortar stores.
Responding to rampant criticism of rising drug prices, pharma giant Eli Lilly will begin selling an authorized generic of its preeminent insulin therapy, Humalog, at half-price.
Forecasting next year’s biggest shifts within the healthcare landscape, Syneos Health has released 2019 Health Trend Ten, available for download now, which explicates ten of the trends that will redefine healthcare globally.
The advent of federal regulatory guidelines for developing gene therapies—which transplant new genes into people’s cells in order to correct disorders—is a crucial moment in the narrative of the still-novel treatment type.
Complications from drug interactions can present patients with whole new afflictions.
The State Supreme Court just resolved a 10-year battle between the Cleveland Clinic and a former patient, retired U.S.
Beginning with its acquisition of PillPack, Amazon’s grand entrance into healthcare continues with its partnership with J.P.
A landmark approval by the FDA will put the first marijuana-derived prescription drug behind pharmacy counters this fall.
A new Deloitte report explores the near-future of blockchain: how seriously the world’s top executives, including many in healthcare, regard the emerging technology and how soon they might invest in it.
Nonprofit hospital system Partners HealthCare has unveiled a joint venture with Circulation, an on-demand rideshare service, through which Medicare patients receive free rides to their doctor’s offices in non-emergencies.
To retail behemoths, the health care realm is growing irresistible.
With funding from Google, Stanford, and venture capital giants Sequoia and Andreessen Horowitz, seven-year-old Zipline has already revolutionized health care in Rwanda.
Advantia Health, a leading-edge medical company committed to empowering women with integrated health care services, announced a new partnership with Elligo Health Research, which will offer Advantia’s clients access to a whole new realm of resources, through clinical trials.
A recent proposal by the U.S.
In a telling new study, pre- and post-surgical efforts by pharmacists yielded staggering effects on patient opioid use.
Amazon Web Services (AWS) has unveiled new machine-learning tools reflecting—and beginning to tackle—some of the greatest challenges facing modern medicine.
GlaxoSmithKline announced that it will acquire Waltham, Massachusetts-based drug company Tesaro, which develops novel cancer treatments, for $5.1 billion cash.
In the first half of this new year, the United States FDA will incentivize many pharmaceutical brands to make their biggest prescription drugs available over the counter.
Tilray, a medical-cannabis producer, has established a new partnership with pharmaceutical giant Novartis, affording the former sales and distribution channels in tens of new countries.
While the term “micro-influencer” may still sound to you like some flippant, gen-Z farce, the side hustle cum way of life just scored serious validation.